RxDoctor Payments DataLook up a doctor →

Earl Lloyd, MD

Internal Medicine · Muncie, INNPI 1669524658

Payments from drug & device makers

$22,875in general payments, 2019–2025

Across 1,565 payments — averaging $14.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Novo Nordisk$3K
  • AstraZeneca$2K
  • GSK$1K
  • Lilly USA, LLC$1K
  • Amgen$1K
  • plus $11K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)338$3,561
Novo Nordisk166$2,523
AstraZeneca75$1,856
GSK142$1,437
Lilly USA, LLC102$1,304
Amgen(2 entities)74$1,178
Arbor Pharmaceuticals, Inc.12$947
Pfizer75$896
Boehringer Ingelheim52$842
Amarin Pharma, Inc.36$604
Astellas Pharma US Inc28$603
Novartis38$538
Johnson & Johnson(2 entities)37$469
Bayer32$464
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC23$456
Otsuka America Pharmaceutical, Inc.19$351
E.r. Squibb & Sons, L.L.C.23$345
Merck30$341
Abbott23$314
Axsome Therapeutics, Inc.12$312
Takeda Pharmaceuticals U.S.A., Inc.18$306
Esperion Therapeutics, Inc.22$278
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)18$268
Idorsia Pharmaceuticals US Inc14$224
Daiichi Sankyo Inc.11$202
Lundbeck LLC14$189
Kowa Pharmaceuticals America, Inc.17$149
Medtronic(2 entities)9$146
Exact Sciences8$131
Biohaven Pharmaceuticals, Inc.10$128
Azurity Pharmaceuticals, Inc.8$126
Ironwood Pharmaceuticals, Inc7$111
Sanofi-aventis U.S. LLC7$105
Eisai Inc.3$68
Seqirus USA Inc4$67
Mylan Specialty L.p.4$59
Teva Pharmaceuticals USA, Inc.4$57
Biohaven Pharmaceutical Holding Company Ltd.4$57
Philips North America LLC2$56
Avanir Pharmaceuticals, Inc.4$51
Edwards Lifesciences2$50
Kerecis Limited1$49
Shield Therapeutics Inc1$43
Stryker1$42
Dexcom, Inc.2$42
Biogen2$38
Phathom Pharmaceuticals, Inc.4$38
Radius Health, Inc.2$36
Grifols USA, LLC2$35
Ionis Pharmaceuticals, Inc.1$31
Vanda Pharmaceuticals Inc.2$30
Currax Pharmaceuticals LLC2$30
Verona Pharma, Inc.1$29
Axonics, Inc.2$28
Ultragenyx Pharmaceutical Inc.2$27
Boston Scientific1$24
SK Life Science, Inc.1$23
Sumitomo Pharma America, Inc.1$19
Amneal Pharmaceuticals LLC1$18
IBSA Pharma Inc.1$15

How this compares

$22,875 in reported general payments places this provider in the 95th percentile of 1,747 internal medicine providers in Indiana.

See all internal medicine providers in Indiana →

Medicare billing

Part B allowed, 2024
$231,607
Medicare patients
443
Services billed
6,400

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Muncie

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →